277 related articles for article (PubMed ID: 29751101)
1. How to measure release from nanosized carriers?
Nothnagel L; Wacker MG
Eur J Pharm Sci; 2018 Jul; 120():199-211. PubMed ID: 29751101
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers.
Torchilin VP
Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
[TBL] [Abstract][Full Text] [Related]
3. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.
Salústio PJ; Pontes P; Conduto C; Sanches I; Carvalho C; Arrais J; Marques HM
AAPS PharmSciTech; 2011 Dec; 12(4):1276-92. PubMed ID: 21948320
[TBL] [Abstract][Full Text] [Related]
4. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology versus other techniques in improving drug dissolution.
Kwok PC; Chan HK
Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
[TBL] [Abstract][Full Text] [Related]
6. Drug nanoparticles: formulating poorly water-soluble compounds.
Merisko-Liversidge EM; Liversidge GG
Toxicol Pathol; 2008 Jan; 36(1):43-8. PubMed ID: 18337220
[TBL] [Abstract][Full Text] [Related]
7. A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions.
Shah DA; Murdande SB; Dave RH
J Pharm Sci; 2016 Jan; 105(1):10-24. PubMed ID: 26580860
[TBL] [Abstract][Full Text] [Related]
8. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Singh G; Pai RS
Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles: A personal experience for formulating poorly water soluble drugs.
Cooper ER
J Control Release; 2010 Feb; 141(3):300-2. PubMed ID: 19822177
[TBL] [Abstract][Full Text] [Related]
10. Correlation of dissolution and disintegration results for an immediate-release tablet.
Nickerson B; Kong A; Gerst P; Kao S
J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticulate strategies for effective delivery of poorly soluble therapeutics.
Gokce EH; Ozyazici M; Souto EB
Ther Deliv; 2010 Jul; 1(1):149-67. PubMed ID: 22816125
[TBL] [Abstract][Full Text] [Related]
12. The dispersion releaser technology is an effective method for testing drug release from nanosized drug carriers.
Janas C; Mast MP; Kirsamer L; Angioni C; Gao F; Mäntele W; Dressman J; Wacker MG
Eur J Pharm Biopharm; 2017 Jun; 115():73-83. PubMed ID: 28213179
[TBL] [Abstract][Full Text] [Related]
13. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
[TBL] [Abstract][Full Text] [Related]
14. Functionally engineered nanosized particles in pharmaceutics: improved oral delivery of poorly water-soluble drugs.
Ozeki T; Tagami T
Curr Pharm Des; 2013; 19(35):6259-69. PubMed ID: 23470003
[TBL] [Abstract][Full Text] [Related]
15. Role of nanotechnology in pharmaceutical product development.
Devalapally H; Chakilam A; Amiji MM
J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
[TBL] [Abstract][Full Text] [Related]
16. Electrospun nanofibers in oral drug delivery.
Ignatious F; Sun L; Lee CP; Baldoni J
Pharm Res; 2010 Apr; 27(4):576-88. PubMed ID: 20143253
[TBL] [Abstract][Full Text] [Related]
17. Review: Nanopreparations for better drug delivery.
Qadir MI
Pak J Pharm Sci; 2017 Nov; 30(6):2301-2309. PubMed ID: 29175803
[TBL] [Abstract][Full Text] [Related]
18. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
19. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
20. Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery.
Lai F; Schlich M; Pireddu R; Corrias F; Fadda AM; Sinico C
Curr Pharm Des; 2015; 21(42):6089-103. PubMed ID: 26503149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
